The abstract is read at the publisher; the summary is JClub's.
Anti-TNF blockade in treatment-naive pediatric Crohn’s disease shifts the intestinal single-cell ecosystem toward an adult, more treatment-refractory state, positioning repeat biopsies between pediatric and adult profiles.
- Why it matters: Most pediatric Crohn’s patients relapse after anti-TNF therapy, yet existing single-cell atlases emphasize treatment-refractory disease, leaving diagnosis-time predictors of severity and response unclear.
- What they did: The study profiled terminal ileum biopsies using clinical data, flow cytometry, histology, and scRNA-seq from treatment-naive pediatric Crohn’s disease (pediCD; n = 14), matched repeat biopsies after treatment (pediCD-treated; n = 8), and non-inflamed pediatric FGIDs (n = 13), analyzing 201,883 baseline single-cell transcriptomes with ARBOL.
- The result: High-resolution analysis identified a pediCD-TIME vector of T cell, innate lymphocyte, myeloid, and epithelial states that distinguishes patients along disease severity and anti-TNF response trajectories, and ARBOL integration linked on-treatment pediatric samples to adult, more refractory states.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
- 1 cited this week
- Open access